| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CAY10576 | CTRPv2 | pan-cancer | AAC | 0.16 | 2e-05 |
| mRNA | ML050 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0003 |
| mRNA | BMS-270394 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0004 |
| mRNA | SR1001 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0009 |
| mRNA | Docetaxel | GDSC1000 | pan-cancer | AAC | -0.099 | 0.001 |
| mRNA | KH-CB19 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.001 |
| mRNA | Sorafenib | CCLE | pan-cancer | AAC | 0.14 | 0.002 |
| mRNA | MLN4924 | GDSC1000 | pan-cancer | AAC | -0.11 | 0.003 |
| mRNA | erismodegib | CTRPv2 | pan-cancer | AAC | 0.11 | 0.004 |
| mRNA | L-685458 | CCLE | pan-cancer | AAC | 0.13 | 0.005 |